Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sosei Group ( (JP:4565) ) has issued an update.
Nxera Pharma Co., Ltd. has successfully completed its buyback and consent solicitation for its existing Euro-yen denominated convertible bonds due 2028. The company received the necessary electronic consents to approve an extraordinary resolution, allowing it to execute a supplemental trust deed and cancel a planned meeting. The tender offer was conducted with a total purchase price of ¥4,837,500,000, leaving ¥27,000,000,000 in principal amount of the bonds outstanding.
The most recent analyst rating on (JP:4565) stock is a Buy with a Yen1400.00 price target. To see the full list of analyst forecasts on Sosei Group stock, see the JP:4565 Stock Forecast page.
More about Sosei Group
Average Trading Volume: 746,442
Technical Sentiment Signal: Strong Sell
Current Market Cap: Yen76.65B
Learn more about 4565 stock on TipRanks’ Stock Analysis page.